Elanco Scour Formula Extra Powder for Oral Solution

Ülke: Birleşik Krallık

Dil: İngilizce

Kaynak: VMD (Veterinary Medicines Directorate)

Aktif bileşen:

Disodium Hydrogen Citrate, Glucose Monohydrate, Glycine, Potassium Citrate Monohydrate, Potassium Dihydrogen Phosphate, Sodium Chloride, Sodium Citrate Dihydrate

Mevcut itibaren:

Elanco Europe Ltd

INN (International Adı):

Disodium Hydrogen Citrate, Glucose Monohydrate, Glycine, Potassium Citrate Monohydrate, Potassium Dihydrogen Phosphate, Sodium Chloride, Sodium Citrate Dihydrate

Farmasötik formu:

Powder for oral solution

Reçete türü:

AVM-GSL - Authorised Veterinary Medicine – General Sales List

Terapötik grubu:

Cattle

Terapötik alanı:

Replacement Agent

Yetkilendirme durumu:

Authorized

Yetkilendirme tarihi:

1993-12-20

Ürün özellikleri

Revised: October 2020
AN: 00844/2020
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Elanco Scour Formula Extra Powder for oral solution
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE INGREDIENTS
%W/W G/SACHET
SACHET A (Electrolyte mix)
Sodium chloride
5.933
4.59
Glycine
3.891
3.01
Potassium dihydrogen phosphate
1.758
1.36
Sodium acid citrate
2.327
1.80
Potassium citrate monohydrate
4.188
3.24
Sodium citrate dihydrate
0.853
0.66
SACHET B
Glucose monohydrate
81.037
62.69
OTHER INGREDIENTS
Erythrosine E127
(Sachet A)
0.007
0.005
When reconstituted as recommended, it contains;
Glycine
20 mmol/L
Sodium
50 mmol/L
Potassium 20 mmol/L
Chloride 39 mmol/L
Citrate
10 mmol/L
Phosphate 5 mmol/L
Glucose 160 mmol/L
3.
PHARMACEUTICAL FORM
Powder for oral solution.
Presented in a pair sachet containing a pink crystalline powder in
one, and a white
crystalline powder in the other
Revised: October 2020
AN: 00844/2020
Page 2 of 5
4. CLINICAL PARTICULARS
4.1 TARGET SPECIES
Calves
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
As an oral rehydration therapy for the treatment of diarrhoea in
calves by reversing the
process of dehydration, acidosis and loss of electrolytes associated
with diarrhoea,
whether caused by bacteria, viruses, cryptosporidia or inappropriate
nutrition.
4.3 CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
i.
Special precautions for use in animals
None.
ii.
Special precautions to be taken by the person administering the
veterinary
medicinal product to animals
None.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
None known.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
Not applicable.
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None known.
The product has been shown to be compatible with oral antibiotics such
as amoxicillin,
ampicillin and oxytetracycline.
4.9 AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
For oral administration only.
Revised: October 2020
AN: 008